Showing results (711-720 of 831) with videos related to

Sort By:
Pageof 84
Acta Neuropathologica Communications|January 18, 2023
Minimal expression of dysferlin prevents development of dysferlinopathy in dysferlin exon 40a knockout miceJoe Yasa, Claudia E Reed, Adam M Bournazos, et al.
BMC Cardiovascular Disorders|January 22, 2020
Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosisCristina Di Stefano, Giulia Bruno, Maria C Arciniegas Calle, et al.
Neuromuscular Disorders : NMD|November 11, 2019
Importance of muscle biopsy to establish pathogenicity of DMD missense and splice variantsHannah F Jones, Samantha J Bryen, Leigh B Waddell, et al.
JACC. Basic to Translational Science|February 15, 2022
The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac InjuryBhurint Siripanthong, Babken Asatryan, Thomas C Hanff, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2019
Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon AgonistVictoria E R Parker, Darren Robertson, Tao Wang, et al.
JACC. Clinical Electrophysiology|February 8, 2023
Inflammation on Endomyocardial Biopsy Predicts Risk of MACE in Undefined Left Ventricular Arrhythmogenic CardiomyopathyGiovanni Peretto, Michela Casella, Marco Merlo, et al.
Respiratory Medicine Case Reports|November 7, 2022
Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature reviewJaleel Jerry G Sweis, Nabil William G Sweis, Christian Ascoli, et al.
JIMD Reports|November 6, 2015
LARS2 Variants Associated with Hydrops, Lactic Acidosis, Sideroblastic Anemia, and Multisystem FailureLisa G Riley, Joëlle Rudinger-Thirion, Klaus Schmitz-Abe, et al.
European Journal of Human Genetics : EJHG|May 30, 2024
Genome sequencing enables diagnosis and treatment of SLC5A6 neuropathyLisa G Riley, Subrata Sabui, Hamid M Said, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2023
Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT)Nitin Ohri, Shruti Jolly, Benjamin T Cooper, et al.
Pageof 84